416 related articles for article (PubMed ID: 22865271)
21. Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment--report of 33 cases.
Perez-Rodriguez J; Lai S; Ehst BD; Fine DM; Bluemke DA
Radiology; 2009 Feb; 250(2):371-7. PubMed ID: 19188312
[TBL] [Abstract][Full Text] [Related]
22. Prophylactic Hemodialysis for Protection Against Gadolinium-Induced Nephrogenic Systemic Fibrosis: A Doll's House.
Yee J
Adv Chronic Kidney Dis; 2017 May; 24(3):133-135. PubMed ID: 28501073
[No Abstract] [Full Text] [Related]
23. Quantitative assessment of dermal cellularity in nephrogenic systemic fibrosis: a diagnostic aid.
Nazarian RM; Mandal RV; Kagan A; Kay J; Duncan LM
J Am Acad Dermatol; 2011 Apr; 64(4):741-7. PubMed ID: 21414498
[TBL] [Abstract][Full Text] [Related]
24. GBCAs and Risk for Nephrogenic Systemic Fibrosis: A Literature Review.
Beam AS; Moore KG; Gillis SN; Ford KF; Gray T; Steinwinder AH; Graham A
Radiol Technol; 2017 Jul; 88(6):583-589. PubMed ID: 28900045
[TBL] [Abstract][Full Text] [Related]
25. Nephrogenic systemic fibrosis: A survey of the use of gadolinium-based contrast agents in Ghana.
Piersson AD; Gorleku PN
Radiography (Lond); 2017 Nov; 23(4):e108-e113. PubMed ID: 28965904
[TBL] [Abstract][Full Text] [Related]
26. Nephrogenic Systemic Fibrosis Manifesting a Decade After Exposure to Gadolinium.
Larson KN; Gagnon AL; Darling MD; Patterson JW; Cropley TG
JAMA Dermatol; 2015 Oct; 151(10):1117-20. PubMed ID: 26017458
[TBL] [Abstract][Full Text] [Related]
27. Nephrogenic systemic fibrosis: a concise review for cardiologists.
Cheong BY; Muthupillai R
Tex Heart Inst J; 2010; 37(5):508-15. PubMed ID: 20978560
[TBL] [Abstract][Full Text] [Related]
28. Nephrogenic systemic fibrosis.
Weinreb JC; Kuo PH
Magn Reson Imaging Clin N Am; 2009 Feb; 17(1):159-67. PubMed ID: 19364606
[TBL] [Abstract][Full Text] [Related]
29. Nephrogenic systemic fibrosis and the use of gadolinium-based contrast agents.
Penfield JG
Pediatr Nephrol; 2008 Dec; 23(12):2121-9. PubMed ID: 18543004
[TBL] [Abstract][Full Text] [Related]
30. Renal function, nephrogenic systemic fibrosis and other adverse reactions associated with gadolinium-based contrast media.
Canga A; Kislikova M; Martínez-Gálvez M; Arias M; Fraga-Rivas P; Poyatos C; de Francisco AL
Nefrologia; 2014; 34(4):428-38. PubMed ID: 25036056
[TBL] [Abstract][Full Text] [Related]
31. Nephrogenic systemic fibrosis and management of high-risk patients.
Altun E; Semelka RC; Cakit C
Acad Radiol; 2009 Jul; 16(7):897-905. PubMed ID: 19375360
[TBL] [Abstract][Full Text] [Related]
32. Nephrogenic systemic fibrosis: histology and gadolinium detection.
Thakral C; Abraham JL
Radiol Clin North Am; 2009 Sep; 47(5):841-53, vi-vii. PubMed ID: 19744599
[TBL] [Abstract][Full Text] [Related]
33. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines.
Stacul F; van der Molen AJ; Reimer P; Webb JA; Thomsen HS; Morcos SK; Almén T; Aspelin P; Bellin MF; Clement O; Heinz-Peer G;
Eur Radiol; 2011 Dec; 21(12):2527-41. PubMed ID: 21866433
[TBL] [Abstract][Full Text] [Related]
34. Influence of excess ligand on Nephrogenic Systemic Fibrosis associated with nonionic, linear gadolinium-based contrast agents.
Semelka RC; Prybylski JP; Ramalho M
Magn Reson Imaging; 2019 May; 58():174-178. PubMed ID: 30471330
[TBL] [Abstract][Full Text] [Related]
35. Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.
Kay J
Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii66-9. PubMed ID: 19022818
[TBL] [Abstract][Full Text] [Related]
36. Gadolinium-Induced Fibrosis.
Todd DJ; Kay J
Annu Rev Med; 2016; 67():273-91. PubMed ID: 26768242
[TBL] [Abstract][Full Text] [Related]
37. Gadolinium contrast agent-induced CD163+ ferroportin+ osteogenic cells in nephrogenic systemic fibrosis.
Swaminathan S; Bose C; Shah SV; Hall KA; Hiatt KM
Am J Pathol; 2013 Sep; 183(3):796-807. PubMed ID: 23867799
[TBL] [Abstract][Full Text] [Related]
38. NSF: still relevant.
Thomsen HS
J Magn Reson Imaging; 2014 Jul; 40(1):11-2. PubMed ID: 24990765
[No Abstract] [Full Text] [Related]
39. Pathomechanisms of nephrogenic systemic fibrosis: new insights.
Gupta A; Shamseddin MK; Khaira A
Clin Exp Dermatol; 2011 Oct; 36(7):763-8. PubMed ID: 21790732
[TBL] [Abstract][Full Text] [Related]
40. Risk of nephrogenic systemic fibrosis in liver transplantation patients.
Chow DS; Bahrami S; Raman SS; Rotchel S; Sayre JW; Busuttil RW; Lu DS
AJR Am J Roentgenol; 2011 Sep; 197(3):658-62. PubMed ID: 21862808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
